91 related articles for article (PubMed ID: 16019529)
41. Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma.
Mangel J; Buckstein R; Imrie K; Spaner D; Crump M; Tompkins K; Reis M; Perez-Ordonez B; Deodhare S; Romans R; Pennell N; Robinson JB; Hewitt K; Richardson P; Lima A; Pavlin P; Berinstein NL
Semin Oncol; 2002 Feb; 29(1S2):56-69. PubMed ID: 28140093
[TBL] [Abstract][Full Text] [Related]
42. Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B-cell lymphoma: mature results of a phase II multicentre study.
Kirschey S; Flohr T; Wolf HH; Frickhofen N; Gramatzki M; Link H; Basara N; Peter N; Meyer RG; Schmitz N; Weidmann E; Banat A; Schulz A; Kolbe K; Derigs G; Theobald M; Hess G
Br J Haematol; 2015 Mar; 168(6):824-34. PubMed ID: 25546611
[TBL] [Abstract][Full Text] [Related]
43. The emerging role of lenalidomide in the management of mantle cell lymphoma (MCL).
Dawar R; Hernandez-Ilizaliturri F
Best Pract Res Clin Haematol; 2012 Jun; 25(2):185-90. PubMed ID: 22687454
[TBL] [Abstract][Full Text] [Related]
44. Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment.
Davis TA; Grillo-López AJ; White CA; McLaughlin P; Czuczman MS; Link BK; Maloney DG; Weaver RL; Rosenberg J; Levy R
J Clin Oncol; 2000 Sep; 18(17):3135-43. PubMed ID: 10963642
[TBL] [Abstract][Full Text] [Related]
45. [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
Al-Ali HK; Wittekind C; Niederwieser D
Dtsch Med Wochenschr; 2007 Aug; 132(33):1688-91. PubMed ID: 17713864
[TBL] [Abstract][Full Text] [Related]
46. High-dose CD20-targeted radioimmunotherapy-based autologous transplantation improves outcomes for persistent mantle cell lymphoma.
Cassaday RD; Stevenson PA; Gooley TA; Chauncey TR; Pagel JM; Rajendran J; Till BG; Philip M; Orozco JJ; Bensinger WI; Holmberg LA; Shustov AR; Green DJ; Smith SD; Libby EN; Maloney DG; Press OW; Gopal AK
Br J Haematol; 2015 Dec; 171(5):788-97. PubMed ID: 26455717
[TBL] [Abstract][Full Text] [Related]
47. Monoclonal antibodies for the treatment of hematologic malignancies: clinical trials in Japan.
Tobinai K
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S90-6. PubMed ID: 12819934
[TBL] [Abstract][Full Text] [Related]
48. High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine.
Romaguera JE; Fayad L; Rodriguez MA; Broglio KR; Hagemeister FB; Pro B; McLaughlin P; Younes A; Samaniego F; Goy A; Sarris AH; Dang NH; Wang M; Beasley V; Medeiros LJ; Katz RL; Gagneja H; Samuels BI; Smith TL; Cabanillas FF
J Clin Oncol; 2005 Oct; 23(28):7013-23. PubMed ID: 16145068
[TBL] [Abstract][Full Text] [Related]
49. Chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma.
Thieblemont C; Antal D; Lacotte-Thierry L; Delwail V; Espinouse D; Michallet AS; Traulle C; Bouafia-Sauvy F; Giraud C; Salles G; Guilhot F; Coiffier B
Cancer; 2005 Oct; 104(7):1434-41. PubMed ID: 16104036
[TBL] [Abstract][Full Text] [Related]
50. High anti-lymphoma activity of bendamustine/mitoxantrone/rituximab in rituximab pretreated relapsed or refractory indolent lymphomas and mantle cell lymphomas. A multicenter phase II study of the German Low Grade Lymphoma Study Group (GLSG).
Weide R; Hess G; Köppler H; Heymanns J; Thomalla J; Aldaoud A; Losem C; Schmitz S; Haak U; Huber C; Unterhalt M; Hiddemann W; Dreyling M;
Leuk Lymphoma; 2007 Jul; 48(7):1299-306. PubMed ID: 17613757
[TBL] [Abstract][Full Text] [Related]
51. Central nervous system relapse in a patient with mantle cell lymphoma in continuous clinical and molecular remission at six years since autografting.
Ladetto M; Sametti S; Astolfi M; Corradini P; Ricca I; Drandi D; Pileri A; Tarella C
Leuk Lymphoma; 2001 Feb; 40(5-6):679-82. PubMed ID: 11426542
[TBL] [Abstract][Full Text] [Related]
52. Mantle cell lymphoma in lymph nodes with metastatic small cell carcinoma of lung: a diagnostic and treatment dilemma.
Kampalath B; Abed N; Chitambar CR; Vantuinen P; Chakrabarty G; Hanson G; Rao RN; Shidham VB; Chang CC
Leuk Lymphoma; 2004 Feb; 45(2):409-14. PubMed ID: 15101734
[TBL] [Abstract][Full Text] [Related]
53. Endoscopic follow-up of 3 cases with gastrointestinal tract involvement of mantle cell lymphoma.
Saito M; Mori A; Irie T; Tanaka M; Morioka M; Ozasa M; Kobayashi T; Saga A; Miwa K; Tanaka S
Intern Med; 2010; 49(3):231-5. PubMed ID: 20118601
[TBL] [Abstract][Full Text] [Related]
54. Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma.
LeBlanc FR; Hasanali ZS; Stuart A; Shimko S; Sharma K; Leshchenko VV; Parekh S; Fu H; Zhang Y; Martin MM; Kester M; Fox T; Liao J; Loughran TP; Evans J; Pu JJ; Spurgeon SE; Aladjem MI; Epner EM
Oncotarget; 2022; 13():986-1002. PubMed ID: 36093297
[TBL] [Abstract][Full Text] [Related]
55. Targeting CD20 in melanoma patients at high risk of disease recurrence.
Pinc A; Somasundaram R; Wagner C; Hörmann M; Karanikas G; Jalili A; Bauer W; Brunner P; Grabmeier-Pfistershammer K; Gschaider M; Lai CY; Hsu MY; Herlyn M; Stingl G; Wagner SN
Mol Ther; 2012 May; 20(5):1056-62. PubMed ID: 22354376
[TBL] [Abstract][Full Text] [Related]
56. Complete remission after autografting for chronic myeloid leukaemia.
Brito-Babapulle F; Apperley JF; Rassool F; Guo AP; Dowding C; Goldman JM
Leuk Res; 1987; 11(12):1115-7. PubMed ID: 2891879
[TBL] [Abstract][Full Text] [Related]
57. Multiple lymphomatous polyposis as a sole presentation of mantle cell lymphoma.
Mar N; Khaled S; Kencana F; Gergis U; Khattak F; Brodsky N; Gotlieb V
J Clin Gastroenterol; 2006 Aug; 40(7):653-4. PubMed ID: 16917415
[No Abstract] [Full Text] [Related]
58. Chemotherapy-free induction in MCL: ready for prime time?
Maddocks K
Blood; 2018 Nov; 132(19):2001-2002. PubMed ID: 30409891
[No Abstract] [Full Text] [Related]
59. Early Onset Neutropenia due to Rituximab Therapy in Mantle Cell Lymphoma: A Case Report.
Nelson BE; Tipton S; Venkatesan R
J Hematol; 2021 Jun; 10(3):136-138. PubMed ID: 34267851
[TBL] [Abstract][Full Text] [Related]
60. COVID-19 in a Post-transplant Heart Recipient Who Developed Aggressive Lymphoma: A Biphasic Course During Rituximab Treatment.
Clerico M; Dogliotti I; Calcagno A; Grimaldi D; Leone S; Ragaini S; Boffini M; Caracciolo D; Ferrero S; Barbero C; Zanotto E; Stroffolini G; Cavallo R; Rinaldi M; Bruno B; Cavallo F
Hemasphere; 2021 Jul; 5(7):e592. PubMed ID: 34131632
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
